TCDB is operated by the Saier Lab Bioinformatics Group

9.B.470.  The Flavin-containing MonoOxygenase 2 (FMO2) Family  

FMO2 catalyzes the oxidative metabolism of numerous xenobiotics, including mainly therapeutic drugs and insecticides that contain a soft nucleophile, most commonly nitrogen or sulfur and participates to their bioactivation (Francois et al. 2009). It specifically catalyzes S-oxygenation of sulfur derived compounds such as thiourea-derived compounds, thioetherorganophosphates to their sulfenic acid (Henderson et al. 2004).  In vitro, it catalyzes S-oxygenation of the second-line antitubercular drugs thiacetazone (TAZ) and ethionamide (ETA), forming a sulfinic acid and a carbodiimide via a postulated sulfenic acid intermediate (Francois et al. 2009).  It also catalyzes S-oxygenation of the thioether-containing organophosphate insecticides, phorate and disulfoton and prevents pathological cardiac hypertrophy by maintaining the ER-mitochondria association through interaction with the IP3R2-Grp75-VDAC1 complex ().Xiao et al. 2025

References associated with 9.B.470 family:

Francois, A.A., C.R. Nishida, P.R. de Montellano, I.R. Phillips, and E.A. Shephard. (2009). Human flavin-containing monooxygenase 2.1 catalyzes oxygenation of the antitubercular drugs thiacetazone and ethionamide. Drug Metab Dispos 37: 178-186. 18948378
Henderson, M.C., S.K. Krueger, J.F. Stevens, and D.E. Williams. (2004). Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione. Chem Res Toxicol 17: 633-640. 15144220
Xiao, C., C. Wang, J. Wang, X. Wu, C. Ke, J. Nan, H. Ding, Y. Xu, Y. Shi, J. Zhao, C. Ni, Q. Liu, J. Li, S. Sheng, H. Chen, J. Cai, T. Zhao, J. Chen, Q. Sun, B. Zhou, J. Wang, W. Zhu, and X. Hu. (2025). FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1. Circulation 151: 1667-1685. 40489543